A meta-analysis on the influence of inflammatory bowel disease on pregnancy

Gut

Volumn 56, Issue 6, 2007, Pages 830-837

  Cornish, J ^a   Tan, E ^a   Teare, J ^a   Teoh, T G ^a   Rai, R ^a   Clark, S K ^b   Tekkis, P P ^a,b  

^a ST MARY S HOSPITAL   (United Kingdom)

^b ST MARK S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CESAREAN SECTION; CLINICAL STUDY; CONGENITAL DISORDER; CONTROLLED STUDY; CROHN DISEASE; ENTERITIS; FEMALE; HIGH RISK POPULATION; HUMAN; LOW BIRTH WEIGHT; PREGNANCY; PREGNANCY DISORDER; PREGNANCY OUTCOME; PREMATURITY; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; ULCERATIVE COLITIS;

ABNORMALITIES; BIRTH WEIGHT; DELIVERY, OBSTETRIC; FEMALE; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, SMALL FOR GESTATIONAL AGE; INFLAMMATORY BOWEL DISEASES; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY OUTCOME; PRENATAL EXPOSURE DELAYED EFFECTS; PUBLICATION BIAS; SENSITIVITY AND SPECIFICITY;

EID: 34249824261     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.2006.108324     Document Type: Article

References (61)

1. Binder V. Epidemiology of IBD during the twentieth century: an integrated view. Best Pract Res Clin Gastroenterol 2004;18:463-79 .
2. Banks BM, Korelitz BI, Zetzel L. The course of non-specific ulcerative colitis: a review of twenty years experience and late results. Gastroenterology 1957;32:983-1012.
3. Lindhagen T, Bohe M, Ekelund G, et al. Fertility and outcome of pregnancy in patients operated on for Crohn's disease. Int J Colorectal Dis 1986;1:25-7.
4. Willoughby CP, Truelove SC. Ulcerative colitis and pregnancy. Gut 1980;21:469-74.
5. Friedman S. Management of inflammatory bowel disease during pregnancy and nursing. Semin Gastrointest Dis 2001;12:245-52.
6. Kornfeld D, Cnattingius S, Ekbom A. Pregnancy outcomes in women with inflammatory bowel disease: a population-based cohort study. Am J Obstet Gynecol 1997;177:942-6.
7. Fonager K, Sorensen HT, Olsen J, et al. Pregnancy outcome for women with Crohn's disease: a follow-up study based on linkage between national registries. Am J Gastroenterol 1998;93:2426-30.
8. Norgard B, Fonager K, Sorensen HT, et al. Birth outcomes of women with ulcerative colitis: a nationwide Danish cohort study. Am J Gastroenterol 2000;95:3165-70.
9. Larzilliere I, Beau P. Chronic inflammatory bowel disease and pregnancy. Case control study. Gastroenterol Clin Biol 1998;22:1056-60.
10. Slattery MM, Morrison JJ. Preterm delivery. Lancet 2002;360:1489-97.
11. Wood NS, Costeloe K, Gibson AT, et al. The EPICure study: associations and antecedents of neurological and developmental disability at 30 months of age following extremely preterm birth. Arch Dis Child Fetal Neonatal Ed 2005;90:F134-40.
12. Petrou S, Mehta Z, Hockley C, et al. The impact of preterm birth on hospital inpatient admissions and costs during the first 5 years of life. Pediatrics 2003;112:1290-7.
13. Shennan AH, Bewley S. Why should preterm births be rising? BMJ 2006;332:924-5.
14. Huddy CL, Johnson A, Hope PL. Educational and behavioural problems in babies of 32-35 weeks gestation. Arch Dis Child Fetal Neonatal Ed 2001;85:F23-8.
15. Saigal S, Stoskopf B, Streiner D, et al. Transition of extremely low-birth-weight infants from adolescence to young adulthood: comparison with normal birth-weight controls. JAMA 2006;295:667- 75.
16. Bartley M, Power C, Blane D, et al. Birth weight and later socioeconomic disadvantage: evidence from the 1958 British cohort study. BMJ 1994;309:1475-8.
17. Davey Smith G, Harding S, Ferrell C, et al. Birth weight of offspring and mortality in the Renfrew and Paisley study: prospective observational study. BMJ 1997;315:1189-93.
18. Clarke M HR. Bringing it all together: Lancet-Cochrane collaborate on systematic reviews. Lancet 2001;357:1278.
19. Stroup DF BJ, Morton SC, Williamson GD, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of observational studies in epidemiology. JAMA 2000;283:2008-12.
20. DerSimonian R LN. Meta-analysis in clinical trials. Control Clin Trials 1986;7:177-88.
21. Athannsiou T, Al-Ruzzeh S, Kumar P, et al. Off-pump myocardial revascularization is associated with less incidence of stroke in elderly patients. Ann Thorac Surg 2004;77:745-53.
22. Mayberry JF, Weterman IT. European survey of fertility and pregnancy in women with Crohn's disease: a case control study by European collaborative group. Gut 1986;27:821-5.
23. Baird DD, Narendranathan M, Sandler RS. Increased risk of preterm birth for women with inflammatory bowel disease. Gastroenterology 1990;99:987-94.
24. Bush MC, Patel S, Lapinski RH, et al. Perinatal outcomes in inflammatory bowel disease. J Matern Fetal Neonatal Med 2004;15:237-41.
25. Dominitz JA, Young JC, Boyko EJ. Outcomes of infants born to mothers with inflammatory bowel disease: a population-based cohort study. Am J Gastroenterol 2002;97:641-8.
26. Elbaz G, Fich A, Levy A, et al. Inflammatory bowel disease and preterm delivery. Int J Gynaecol Obstet 2005;90:193-7.
27. Fedorkow DM, Persaud D, Nimrod CA. Inflammatory bowel disease: a controlled study of late pregnancy outcome. Am J Obstet Gynecol 1989;160:998-1001.
28. Ludvigsson JF, Ludvigsson J. Inflammatory bowel disease in mother or father and neonatal outcome. Acta Paediatr 2002;91:145-51.
29. Moser MA, Okun NB, Mayes DC, et al. Crohn's disease, pregnancy, and birth weight. Am J Gastroenterol 2000;95:1021-6.
30. Porter RJ, Stirrat GM. The effects of inflammatory bowel disease on pregnancy: a case-controlled retrospective analysis. Br J Obstet Gynaecol 1986;93:1124-31.
31. Counihan TC, Roberts PL, Schoetz DJ Jr, et al. Fertility and sexual and gynecologic function after ileal pouch-anal anastomosis. Dis Colon Rectum 1994;37:1126-9.
32. Juhasz ES, Fozard B, Dozois RR, et al. Ileal pouch-anal anastomosis function following childbirth. An extended evaluation. Dis Colon Rectum 1995;38:159-65.
33. Metcalf A, Dozois RR, Beart RW Jr, et al. Pregnancy following ileal pouch-anal anastomosis. Dis Colon Rectum 1985;28:859-61.
34. Nelson H, Dozois RR, Kelly KA, et al. The effect of pregnancy and delivery on the ileal pouch-anal anastomosis functions. Dis Colon Rectum 1989;32:384-8.
35. Remzi FH, Gorgun E, Bast J, et al. Vaginal delivery after ileal pouch-anal anastomosis: a word of caution. Dis Colon Rectum 2005;48:1691-9.
36. Morales M, Berney T, Jenny A, et al. Crohn's disease as a risk factor for the outcome of pregnancy. Hepatogastroenterology 2000;47:1595-8.
37. Norgard B, Puho E, Pedersen L, et al. Risk of congenital abnormalities in children born to women with ulcerative colitis: a population-based, case-control study. Am J Gastroenterol 2003;98:2006-10.
38. Nielsen OH, Andreasson B, Bondesen S, et al. Pregnancy in ulcerative colitis. Scand J Gastroenterol 1983;18:735-42.
39. Woolfson K, Cohen Z, McLeod RS. Crohn's disease and pregnancy. Dis Colon Rectum 1990;33:869-73.
40. Katz JA, Antoni C, Keenan GF, et al. Outcome of pregnancy in women receiving infliximab for the treatment of Crohn's disease and rheumatoid arthritis. Am J Gastroenterol 2004;99:2385-92.
41. Stanton C IJ, Rahman H, Wilczynska-Ketende K, et al. Stillbirth rates: delivering estimates in 190 countries. Lancet 2006;367:1487-94.
42. Baiocco PJ, Korelitz BI. The influence of inflammatory bowel disease and its treatment on pregnancy and fetal outcome. J Clin Gastroenterol 1984;6:211-16.
43. Bell CM, Habal FM. Safety of topical 5-aminosalicylic acid in pregnancy. Am J Gastroenterol 1997;92:2201-2.
44. Colombel JF, Brabant G, Gubler MC, et al. Renal insufficiency in infant: side-effect of prenatal exposure to mesalazine? Lancet 1994;344:620-1.
45. Diav-Citrin O, Park YH, Veerasuntharam G, et al. The safety of mesalamine in human pregnancy: a prospective controlled cohort study. Gastroenterology 1998;114:23-8.
46. Marteau P, Tennenbaum R, Elefant E, et al. Foetal outcome in women with inflammatory bowel disease treated during pregnancy with oral mesalazine microgranules. Aliment Pharmacol Ther 1998;12:1101-8.
47. Mogadam M DW, Korelitz BI, Ahmed SW. Pregnancy in inflammatory bowel disease: effect of sulfasalazine and corticosteroids on fetal outcome. Gastroenterology 1981;80:70-2.
48. Moskovitz DN, Bodian C, Chapman M, et al. The effect on the fetus of medications used to treat pregnant inflammatory bowel disease patients. Am J Gastroenterol 2004;99:656.
49. Nielsen OH, Andreasson B, Bondesen S, et al. Pregnancy in Crohn's disease. Scand J Gastroenterol 1984;19:724-32.
50. Norgard B, Fonager K, Pedersen L, et al. Birth outcome in women exposed to 5-aminosalicylic acid during pregnancy: a Danish cohort study. Gut 2003;52:243-7.
51. Trallori G, d'Albasio G, Bardazzi G, et al. 5-Aminosalicylic acid in pregnancy: clinical report, Ital J Gastroenterol 1994;26:75-8.
52. Willoughby CP, Truelove SC. Ulcerative colitis and pregnancy. Gut 1980;21:469-74.
53. Alsteod EM, Ritchie JK, Lennard-Jones JE, et al. Safety of azathioprine in pregnancy in inflammatory bowel disease. Gastroenterology 1990;99:443-6.
54. Francella A DA, Bodian C, Rubin P, et al. The safety of 6-mercaptopurine for childbearing patients with inflammatory bowel disease: a retrospective cohort study. Gastroenterology 2003;124:9-17.
55. Norgard B, Pedersen L, Fonager K, et al. Azathioprine, mercaptopurine and birth outcome: a population-based cohort study. Aliment Pharmacol Ther 2003;17:827-34.
56. Fraser FC, Sajoo A. Teratogenic potential of corticosteroids in humans. Teratology 1995;51:45-6.
57. Mahadevan U, Kane S, Sandborn WJ, et al. Intentional infliximab use during pregnancy for induction or maintenance of remission in Crohn's disease. Aliment Pharmacol Ther 2005;21:733-8.
58. Savitz DA, Hertz-Picciotto I, Poole C, et al. Epidemiologic measures of the course and outcome of pregnancy. Epidemiol Rev 2002;24:91-101.
59. Finer LB HK. Abortion incidence and services in the United States in 2000. Perspect Sex Reprod Health 2003;35:6-15.
60. Say L, Donner A, Gulmezoglu AM, et al. The prevalence of stillbirths: a systematic review. Reprod Health 2006;3:1.
61. ONS. Birth statistics, FM1 no 33 (revised).National Statistics, 2006:44.